Akira Takazawa - Publications

IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.

Journal: Future oncology (London, England)

Published: June 19, 2026

MRI-Based Surgical Margin Assessment in Dermatofibrosarcoma Protuberans: Correlation With Pathological Extent.

Journal: The Journal of dermatology

Published: May 06, 2026

Molecular Characterization and Its Clinical Application of GNAS Variants in Intramuscular Myxoma.

Journal: Cancer medicine

Published: June 25, 2025

Clinical considerations for non-operative treatment of spinal metastases with intermediate instability.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: December 15, 2024

Two-Staged Reconstruction of Extensor Tendons After Wide Resection of Clear Cell Sarcoma at the Anterior Ankle: A Case Report.

Journal: JBJS case connector

Published: September 21, 2023

Muscle strength and functional recovery for soft-tissue sarcoma of the thigh: a prospective study.

Journal: International journal of clinical oncology

Published: December 23, 2022

The usefulness of immunohistochemistry for phosphohistone H3 as a prognostic factor in myxoid liposarcoma.

Journal: Scientific reports

Published: October 02, 2022

Antitumor Effect of Sclerostin against Osteosarcoma.

Journal: Cancers

Published: October 31, 2021

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 02, 2021

Influence of the adductor compartment resection on muscle strength and postoperative function in soft-tissue sarcoma of the thigh.

Journal: Japanese journal of clinical oncology

Published: August 09, 2021

Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 25, 2021

Distal femoral impaction bone grafting in revision for tumor endoprosthesis.

Journal: The Knee

Published: September 23, 2020